The Hamner Institutes and The University of North Carolina-Chapel Hill Announce New Research Partnership in Drug Safety Sciences

RESEARCH TRIANGLE PARK, N.C., Sept. 2, 2008--Drug Safety Alliance (DSA), a global leader in pharmaceutical safety and pharmacovigilance, has announced the addition of industry veteran Deena B. Wegner as vice president, business development and strategy.

HOUSTON, Aug. 20, 2008--Pharm-Olam International Ltd. (POI), a multi-national, full service CRO to pharmaceutical and biotech industries expands pharmacovigilance services by providing electronic adverse event management and reporting.

SAN BRUNO, Calif.--(BUSINESS WIRE)--Aug 13, 2008 - Cord Blood Registry (CBR), the global leader in umbilical cord blood banking, announced today that for the quarter ended June 30, 2008, the company achieved a 32 percent increase in revenue compared to the same quarter in 2007. In addition, cash res...

LONDON, Aug. 6, 2008-The Medicines and Healthcare products Regulatory Agency (MHRA) has today given approval for a medicine to be made available from a pharmacist without a doctor’s prescription to treat chlamydia. The azithromycin pill, which will be called “Clamelle”, will be available to buy by p...

Featuring Four Keynote Presentations, Four Pre-Conference Summits, Six Therapeutics Conference Topics, Three Post-Conference Workshops and Over One Hundred and Seventy Exhibitors

YORK, England, July 30, 2008--ACM-Pivotal (Europe), which provides clinical trials services to the pharmaceutical and biotech industries, has had its College of American Pathologists (CAP) accreditation renewed for the second time.

WILMINGTON, N.C., July 30, 2008--AAIPharma has received its second certification from a European Union (EU) regulatory body that the company's operations are in compliance with EU Good Manufacturing Practice (GMP) regulations. Following an audit of AAIPharma's manufacturing, testing and stability...

LONDON, July 10, 2008--Andrew Jenkins has been appointed Director, Client Services, at Wells Healthcare Communications Ltd, part of the uniquely configured Interlace Global group of companies. He will be responsible for the strategic direction and management of key global accounts as well as taking ...

KENT, England, July 10, 2008--Dr Lev Fedyniak has been appointed Director of Medical Education at Wells Healthcare Communications Ltd, part of the Interlace Global group of companies. His key role at Wells will be to provide strategic clinical insight to education programmes for Wells’ international...